MX2017004446A - Metodos para separar diastereoisomeros de gemcitabina-fosfato. - Google Patents

Metodos para separar diastereoisomeros de gemcitabina-fosfato.

Info

Publication number
MX2017004446A
MX2017004446A MX2017004446A MX2017004446A MX2017004446A MX 2017004446 A MX2017004446 A MX 2017004446A MX 2017004446 A MX2017004446 A MX 2017004446A MX 2017004446 A MX2017004446 A MX 2017004446A MX 2017004446 A MX2017004446 A MX 2017004446A
Authority
MX
Mexico
Prior art keywords
gemcitabine
phosphate
separating
methods
alaninyl
Prior art date
Application number
MX2017004446A
Other languages
English (en)
Inventor
Griffith Hugh
Original Assignee
Nucana Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucana Biomed Ltd filed Critical Nucana Biomed Ltd
Publication of MX2017004446A publication Critical patent/MX2017004446A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta solicítud está relacionada a un método para separar los diastereoisómeros de fosfato de gemcitabina-[fenil-benzoxi-L-anani nil)]-fosfato (NUC-1031) usando cristalización; en particular, la cristalización de alcohol isopropílico proporciona gemcitabina-[fenil-benzoxi-L-alaninil)]-(S)-fosfato en forma altamente diastereoisoméricamente pura; esta solicitud también está relacionada a una forma cristalina de gemcitabina-[fenil-benz oxi-L-alaninil)]-(S)-fosfato.
MX2017004446A 2014-10-06 2015-09-29 Metodos para separar diastereoisomeros de gemcitabina-fosfato. MX2017004446A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1417644.0A GB201417644D0 (en) 2014-10-06 2014-10-06 Method of separating phosphate diastereoisomers
PCT/GB2015/052839 WO2016055769A1 (en) 2014-10-06 2015-09-29 Methods of separating gemcitabine-phosphate diastereoisomers

Publications (1)

Publication Number Publication Date
MX2017004446A true MX2017004446A (es) 2017-06-19

Family

ID=51946917

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017004446A MX2017004446A (es) 2014-10-06 2015-09-29 Metodos para separar diastereoisomeros de gemcitabina-fosfato.
MX2020003758A MX2020003758A (es) 2014-10-06 2015-09-29 Metodos para separar diastereoisomeros de gemcitabina-fosfato.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020003758A MX2020003758A (es) 2014-10-06 2015-09-29 Metodos para separar diastereoisomeros de gemcitabina-fosfato.

Country Status (29)

Country Link
US (1) US10669300B2 (es)
EP (2) EP3204398B1 (es)
JP (2) JP6893172B2 (es)
KR (1) KR102532498B1 (es)
CN (2) CN107108682B (es)
AU (2) AU2015329767B2 (es)
CA (1) CA2959977C (es)
CL (1) CL2017000819A1 (es)
CY (1) CY1123061T1 (es)
DK (1) DK3204398T3 (es)
EA (1) EA033118B1 (es)
ES (1) ES2793957T3 (es)
GB (1) GB201417644D0 (es)
HR (1) HRP20200849T1 (es)
HU (1) HUE050882T2 (es)
IL (1) IL251125B (es)
LT (1) LT3204398T (es)
MA (1) MA41039B1 (es)
ME (1) ME03730B (es)
MX (2) MX2017004446A (es)
MY (1) MY183302A (es)
PH (1) PH12017500586A1 (es)
PL (1) PL3204398T3 (es)
PT (1) PT3204398T (es)
RS (1) RS60634B1 (es)
SG (2) SG11201701885UA (es)
SI (1) SI3204398T1 (es)
WO (1) WO2016055769A1 (es)
ZA (1) ZA201701723B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317009D0 (en) * 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
MY176133A (en) 2012-11-16 2020-07-24 Nucana Biomed Ltd Process for preparing nucleoside prodrugs
TWI695718B (zh) 2014-06-25 2020-06-11 英商努卡那公眾有限公司 前藥
AU2015278900B2 (en) 2014-06-25 2019-04-04 NuCana plc Formulation comprising a gemcitabine-prodrug
GB201417644D0 (en) 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
CN112156102B (zh) * 2015-09-16 2023-10-03 济南高合医疗科技有限公司 一种nuc-1031单一异构体的晶型及其制备方法
CN106543220A (zh) * 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 氨基磷酸酯化合物及其制备方法和晶体
CN106543252A (zh) * 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 核苷氨基磷酸酯类前药的制备方法及其中间体
JP7038653B2 (ja) 2015-10-05 2022-03-18 ニューカナ パブリック リミテッド カンパニー 併用療法
AU2016367237B2 (en) 2015-12-11 2020-12-24 Laurus Labs Limited Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug NUC-1031
GB201522771D0 (en) * 2015-12-23 2016-02-03 Nucana Biomed Ltd Crystalline form of a phosphate derivative
CN107652342A (zh) * 2016-07-23 2018-02-02 江苏万高药业股份有限公司 核苷氨基磷酸酯类前药的多晶型及其制备方法
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
CN107400156B (zh) * 2017-09-19 2020-01-31 北京大学 一种分离麦角甾烷型三萜25r-与25s-差向异构体的方法
CN115028594A (zh) * 2020-06-03 2022-09-09 吴卫东 恩替他滨药用前体化合物及其制备方法和医学用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1254092B1 (en) * 2000-02-11 2004-01-21 Degussa AG Resolution of dl-racemic mixtures
GB0317009D0 (en) * 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
FR2954310B1 (fr) * 2009-12-18 2014-07-25 Univ Rouen Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle
MY176133A (en) * 2012-11-16 2020-07-24 Nucana Biomed Ltd Process for preparing nucleoside prodrugs
WO2014204856A1 (en) 2013-06-17 2014-12-24 Catabasis Pharmaceuticals, Inc. Fatty acid anticancer derivatives and their uses
US10030044B2 (en) * 2013-11-27 2018-07-24 Idenix Pharmaceuticals Llc Nucleotides for the treatment of liver cancer
TWI695718B (zh) 2014-06-25 2020-06-11 英商努卡那公眾有限公司 前藥
AU2015278900B2 (en) * 2014-06-25 2019-04-04 NuCana plc Formulation comprising a gemcitabine-prodrug
CN106795198B (zh) 2014-07-22 2019-09-06 努卡那公共有限公司 用于制备吉西他滨-[苯基(苄氧基-l-丙氨酸基)]磷酸酯的方法
GB201417644D0 (en) 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
EP3415149A1 (en) 2015-05-14 2018-12-19 NuCana plc Cancer treatments
JP7038653B2 (ja) 2015-10-05 2022-03-18 ニューカナ パブリック リミテッド カンパニー 併用療法
AU2016367237B2 (en) 2015-12-11 2020-12-24 Laurus Labs Limited Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug NUC-1031
MX2018007772A (es) 2015-12-23 2019-07-04 NuCana plc Terapia de combinacion.
AU2015418015B2 (en) 2015-12-23 2021-12-09 NuCana plc Combination therapy
GB201522771D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Crystalline form of a phosphate derivative

Also Published As

Publication number Publication date
JP6893172B2 (ja) 2021-06-23
PL3204398T3 (pl) 2020-11-16
ZA201701723B (en) 2023-11-29
CL2017000819A1 (es) 2017-11-03
KR102532498B1 (ko) 2023-05-12
GB201417644D0 (en) 2014-11-19
IL251125B (en) 2020-07-30
AU2015329767B2 (en) 2020-03-12
AU2020203714B2 (en) 2021-07-22
CY1123061T1 (el) 2021-10-29
AU2015329767A1 (en) 2017-04-13
US10669300B2 (en) 2020-06-02
JP2017530172A (ja) 2017-10-12
JP2020128392A (ja) 2020-08-27
ES2793957T3 (es) 2020-11-17
EP3204398A1 (en) 2017-08-16
PT3204398T (pt) 2020-05-28
SG11201701885UA (en) 2017-04-27
WO2016055769A1 (en) 2016-04-14
IL251125A0 (en) 2017-04-30
CN112552362A (zh) 2021-03-26
MX2020003758A (es) 2021-10-26
PH12017500586A1 (en) 2017-08-30
JP6967625B2 (ja) 2021-11-17
CA2959977A1 (en) 2016-04-14
DK3204398T3 (da) 2020-06-02
MA41039B1 (fr) 2020-08-31
CN107108682B (zh) 2020-12-18
EP3204398B1 (en) 2020-05-13
SI3204398T1 (sl) 2020-09-30
ME03730B (me) 2021-01-20
HRP20200849T1 (hr) 2020-10-30
CN107108682A (zh) 2017-08-29
CA2959977C (en) 2024-01-02
EA033118B1 (ru) 2019-08-30
HUE050882T2 (hu) 2021-01-28
LT3204398T (lt) 2020-09-10
EP3725794A1 (en) 2020-10-21
AU2020203714A1 (en) 2020-06-25
SG10201902952SA (en) 2019-05-30
BR112017006855A2 (pt) 2017-12-12
US20170226147A1 (en) 2017-08-10
EA201790794A1 (ru) 2017-07-31
MY183302A (en) 2021-02-18
KR20170090413A (ko) 2017-08-07
RS60634B1 (sr) 2020-09-30

Similar Documents

Publication Publication Date Title
PH12017500586A1 (en) Methods of separating gemcitabine-phosphate diastereoisomers
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
MX2016017355A (es) Lipido que comprende acido docosapentaenoico.
MX2016002288A (es) Auxiliares de extraccion de aceite en procesamiento de grano.
EP3578511A4 (en) METHOD FOR PRODUCING LITHIUM DIFLUORPHOSPHATE
EP4233562A3 (en) Method for producing allulose crystals
MX2018014764A (es) Metodo para producir acido 3-hidroxiadipico.
IN2014MU00455A (es)
MX2018007782A (es) Forma cristalina de gemcitabina.
MX2018002731A (es) Proceso para la elaboracion de esteres de cianohidrina que contienen fosforo.
EP3572374A4 (en) LITHIUM DIFLUOROPHOSPHATE PRODUCTION METHOD
MX2017013855A (es) Metodo para la separacion de proteina y otras impurezas de polisacaridos capsulares microbianos.
MX2018014769A (es) Metodo para producir acido a-hidromuconico.
MX2018002729A (es) Proceso para la elaboracion de esteres de cianohidrina que contienen fosforo.
MX2018002730A (es) Proceso para producir esteres de cianhidrina que contienen fosforo.
MX2016001038A (es) Composiciones de cocristalizacion y fusión parcial.
MX2018002726A (es) Proceso para producir esteres de cianhidrina que contienen fosforo.
EP3385368A4 (en) PROCESS FOR PRODUCING MESENCHYMAL STEM CELLS
EP3778913A4 (en) PROCESS FOR PREPARING A PURIFIED SUGAR SOLUTION
IN2014CH00444A (es)
WO2018198101A3 (en) Processes for the preparation of crystalline form of eluxadoline
MY188557A (en) Lipid comprising docosapentaenoic acid
IN2015CH00214A (es)
MX2019004171A (es) Planta y solucion remojada que comprende tagatosa, y metodo para producir la misma.
IN2013CH04330A (es)

Legal Events

Date Code Title Description
FG Grant or registration